Innotive Diagnostics
Developer of a cartridge-based point-of-care diagnostic system for urinary tract infections (UTIs). The company has transitioned laboratory assays into automated prototypes that perform bacterial enumeration, identification and antimicrobial susceptibility testing (AST) at the point of care, targeting delivery of ID and AST results within 60 minutes to support faster, targeted antibiotic prescribing and improved antimicrobial stewardship.
Industries
Nr. of Employees
small (1-50)
Innotive Diagnostics
Second Floor, Riverside South Building, Walcot Yard, Walcot Street, Bath, BA1 5BG, UK
Products
Point-of-care UTI diagnostic system (prototype)
A cartridge-based point-of-care diagnostic instrument and disposable cartridges designed to perform bacterial enumeration, morphology-based identification and antimicrobial susceptibility testing from urine samples, targeting ID in minutes and AST within 60 minutes.
Point-of-care UTI diagnostic system (prototype)
A cartridge-based point-of-care diagnostic instrument and disposable cartridges designed to perform bacterial enumeration, morphology-based identification and antimicrobial susceptibility testing from urine samples, targeting ID in minutes and AST within 60 minutes.
Services
Planned validation of prototype diagnostic systems using clinical specimens and support for real-world clinical pilot studies.
Support for go-to-market strategy refinement through accelerator participation and mentorship.
Planned validation of prototype diagnostic systems using clinical specimens and support for real-world clinical pilot studies.
Support for go-to-market strategy refinement through accelerator participation and mentorship.
Expertise Areas
- Point-of-care diagnostics
- Antimicrobial susceptibility testing (AST)
- Assay development for infectious disease
- Diagnostic device prototyping
Key Technologies
- Fluorescence microscopy
- Time-lapse imaging
- Automated image analysis algorithms
- Cartridge-based sample processing
News & Updates
Awarded a £1m grant from PACE to support development and large-scale clinical specimen testing of its rapid UTI diagnostic prototypes prior to real-world pilot studies.
Closed a seed funding round totaling £3.2m from UK and international investors to advance prototype development and regulatory preparation.
Appointment of an experienced microbiology and IVD development lead to support late-stage prototype testing and validation.
Recognised as a university spinoff translating scientific research into a diagnostic product addressing a societal problem.
Selected for a six-month accelerator program to refine US market strategy and access mentorship and facilities.
Shortlisted as a start-up recognised for work on rapid UTI diagnostics.
Awarded a £1m grant from PACE to support development and large-scale clinical specimen testing of its rapid UTI diagnostic prototypes prior to real-world pilot studies.
Closed a seed funding round totaling £3.2m from UK and international investors to advance prototype development and regulatory preparation.
Appointment of an experienced microbiology and IVD development lead to support late-stage prototype testing and validation.
Recognised as a university spinoff translating scientific research into a diagnostic product addressing a societal problem.
Selected for a six-month accelerator program to refine US market strategy and access mentorship and facilities.
Shortlisted as a start-up recognised for work on rapid UTI diagnostics.